KT185 是口服有效的、能透过血脑屏障的ABHD6 的选择性抑制剂，其在 Neuro2A 细胞中测得的 IC50 值为0.21 nM。
CAS：1472640-86-0
分子式：C32H33N5O2
分子量：519.64
纯度：98%
存储：Store at -20°C

Background:

KT185 is an orally-bioavailable, brain-penetrant and selective ABHD6 inhibitor, with an IC50 0.21 nM in Neuro2A cells[1]. IC50: ABHD6 (0.21 nM in Neuro2A cells)[1].

[1]. Hsu KL, et al. Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of α/β-hydrolase domain containing 6 (ABHD6). J Med Chem. 2013 Nov 14;56(21):8270-9.